News
Asianet Newsable on MSN30m
Sarepta Pauses Shipments Of DMD Drug Elevidys Amid FDA Label Review, Stock Tumbles After-HoursH.C. Wainwright slashed its price target to $0, assigning a 'Sell' rating and saying Sarepta has no remaining intrinsic value ...
Stockhead on MSN47m
Health Check: Bug buster Genetic Signatures’ US expansion is a jumbo-sized taskTummy bug testing outfit Genetic Signatures is honing its operations after finding its company-making US expansion was harder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback